Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study).

Keiichiro IshibashiToru AoyamaMasahito KotakaHironaga SatakeYasushi TsujiMasato KataokaMasato NakamuraNaoki NagataJunichi SakamotoKoji ObaHideyuki Mishima

Published in: Cancer chemotherapy and pharmacology (2021)

First-line chemotherapy with re-introduction of OX more than 6 months after adjuvant chemotherapy including OX can be used safely with expected efficacy for relapsed colon cancer patients.

Keyphrases

phase ii study
locally advanced
acute lymphoblastic leukemia
acute myeloid leukemia
multiple myeloma
diffuse large b cell lymphoma
hodgkin lymphoma
open label
rectal cancer
squamous cell carcinoma
radiation therapy
placebo controlled